ArticleAdvanced therapeutics2023

Identification of an ALK-2 inhibitor as an agonist for intercellular exchange and tumor delivery of nanomaterial.

Xian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.